160 related articles for article (PubMed ID: 17192662)
1. Bioscavenger for protection from toxicity of organophosphorus compounds.
Saxena A; Sun W; Luo C; Myers TM; Koplovitz I; Lenz DE; Doctor BP
J Mol Neurosci; 2006; 30(1-2):145-8. PubMed ID: 17192662
[TBL] [Abstract][Full Text] [Related]
2. Bioscavengers for the protection of humans against organophosphate toxicity.
Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():167-71. PubMed ID: 16293236
[TBL] [Abstract][Full Text] [Related]
3. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
4. Enzymes as pretreatment drugs for organophosphate toxicity.
Doctor BP; Raveh L; Wolfe AD; Maxwell DM; Ashani Y
Neurosci Biobehav Rev; 1991; 15(1):123-8. PubMed ID: 2052184
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase.
Allon N; Raveh L; Gilat E; Cohen E; Grunwald J; Ashani Y
Toxicol Sci; 1998 Jun; 43(2):121-8. PubMed ID: 9710953
[TBL] [Abstract][Full Text] [Related]
6. Acetylcholinesterase inhibition resulting from exposure to inhaled OP can be prevented by pretreatment with BChE in both macaques and minipigs.
Rosenberg Y; Saxena A
Neuropharmacology; 2020 Sep; 174():108150. PubMed ID: 32442543
[TBL] [Abstract][Full Text] [Related]
7. Naturally Occurring Genetic Variants of Human Acetylcholinesterase and Butyrylcholinesterase and Their Potential Impact on the Risk of Toxicity from Cholinesterase Inhibitors.
Lockridge O; Norgren RB; Johnson RC; Blake TA
Chem Res Toxicol; 2016 Sep; 29(9):1381-92. PubMed ID: 27551784
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
9. Novel bifunctional hybrid small molecule scavengers for mitigating nerve agents toxicity.
Amitai G; Gez R; Raveh L; Bar-Ner N; Grauer E; Chapman S
Chem Biol Interact; 2016 Nov; 259(Pt B):187-204. PubMed ID: 27129421
[TBL] [Abstract][Full Text] [Related]
10. Human serum butyrylcholinesterase: in vitro and in vivo stability, pharmacokinetics, and safety in mice.
Saxena A; Sun W; Luo C; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():199-203. PubMed ID: 16263104
[TBL] [Abstract][Full Text] [Related]
11. Conjugates of human serum butyrylcholinesterase and nerve agents are behaviorally safe in rhesus macaques.
Saxena A; Myers TM; Sipos ML
Chem Biol Interact; 2021 Aug; 344():109499. PubMed ID: 33961835
[TBL] [Abstract][Full Text] [Related]
12. Human plasma-derived BuChE as a stoichiometric bioscavenger for treatment of nerve agent poisoning.
Mumford H; Docx CJ; Price ME; Green AC; Tattersall JE; Armstrong SJ
Chem Biol Interact; 2013 Mar; 203(1):160-6. PubMed ID: 22981459
[TBL] [Abstract][Full Text] [Related]
13. Comparison of polyethylene glycol-conjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds.
Cohen O; Kronman C; Raveh L; Mazor O; Ordentlich A; Shafferman A
Mol Pharmacol; 2006 Sep; 70(3):1121-31. PubMed ID: 16801396
[TBL] [Abstract][Full Text] [Related]
14. Cholinesterases as scavengers for organophosphorus compounds: protection of primate performance against soman toxicity.
Doctor BP; Blick DW; Caranto G; Castro CA; Gentry MK; Larrison R; Maxwell DM; Murphy MR; Schutz M; Waibel K
Chem Biol Interact; 1993 Jun; 87(1-3):285-93. PubMed ID: 8343986
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of human serum butyrylcholinesterase against sarin vapor.
Saxena A; Sun W; Dabisch PA; Hulet SW; Hastings NB; Jakubowski EM; Mioduszewski RJ; Doctor BP
Chem Biol Interact; 2008 Sep; 175(1-3):267-72. PubMed ID: 18597747
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic and neuroprotective efficacy of pharmacological pretreatment and antidotal treatment of acute tabun or soman poisoning with the emphasis on pretreatment drug PANPAL.
Kassa J
Arh Hig Rada Toksikol; 2006 Dec; 57(4):427-34. PubMed ID: 17265682
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary delivery of an aerosolized recombinant human butyrylcholinesterase pretreatment protects against aerosolized paraoxon in macaques.
Rosenberg YJ; Laube B; Mao L; Jiang X; Hernandez-Abanto S; Lee KD; Adams R
Chem Biol Interact; 2013 Mar; 203(1):167-71. PubMed ID: 23178380
[TBL] [Abstract][Full Text] [Related]
18. Safety and pharmacokinetics of human serum butyrylcholinesterase in guinea pigs.
Sun W; Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():428-9. PubMed ID: 16429577
[TBL] [Abstract][Full Text] [Related]
19. The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase.
Raveh L; Grauer E; Grunwald J; Cohen E; Ashani Y
Toxicol Appl Pharmacol; 1997 Jul; 145(1):43-53. PubMed ID: 9221822
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and immunologic consequences of exposing macaques to purified homologous butyrylcholinesterase.
Rosenberg Y; Luo C; Ashani Y; Doctor BP; Fischer R; Wolfe G; Saxena A
Life Sci; 2002 Nov; 72(2):125-34. PubMed ID: 12417246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]